Global Smart Biopsy Devices Market Size, Share, Growth, Key Players, Opportunity and Forecast To 2027

A biopsy is a medical test in which a piece of tissue or a sample of cells is removed from the body in order to analyze and characterize it. The test is recommended to determine whether an individual have cancer or some other condition when an abnormality in the tissue or body is observed in the initial test. While imaging tests, such as X-rays, are unable to differentiate cancerous cells from noncancerous cells. For most cancers, the only precise diagnosis is to perform biopsy test.

GET SAMPLE COPY @ https://www.reportocean.com/industry-verticals/sample-request?report_id=bw1405

For diagnosis of cancer, a wide range of biopsies are used including bone marrow, endoscopic, needle, skin, vacuum-assisted and surgical biopsy. Apart from diagnosing cancer, it can also determine how aggressively the cancer cells are multiplying.

In 2018, the global prevalence of cancer was estimated 18.1 million new cases of cancer and 9.6 million deaths from cancer. According to the American Cancer Society, 1.8 million new cancer cases and 606,520 cancer deaths are reported to occur in the United States in 2020.

There are various non-invasive imaging technologies and techniques which aid in biopsy for easy examination of the concerned area of the patient. These tools are designed to fulfill the requirement of the real-time cancer tissue characterization, so-called smart biopsies, which are already used in hospitals to increase the rate and possibility of cancer diagnosis.

Market Insights

Tissue samples are analyzed in biopsy in order to find out whether a suspicious lump is harmless or dangerous. The doctor procures a small sample of tissue from the body and sends it to for examination under microscope in laboratory.

According to Report Ocean study, Global Smart Biopsy Devices Market was approximately USD 2.5 billion in 2019 and is anticipated to grow at a rate of more than 5.7% over the forecast period 2020-2027. This report forecasts growth of Smart Biopsy Devices Market at global level, provides an insight of the latest trends and analysed the market based on the application of biopsy.

By Application

• Breast cancer
• Skin cancer
• Liver cancer
• Prostate cancer
• Others

Availability of wide range of biopsies, the increasing prevalence of cancer around the world and increasing number of minimally invasive surgical procedures preferred due to the benefits such as shorter hospital stay and comparatively less pain than open surgery. These facts alleviate the smart biopsy device market globally. Contrary to this, clinical problems associated with needle biopsy and complaints related to cancer screening procedures restrains the market growth.

Considering the applications, prostate cancer in men and breast cancer in women are the most common cause of death in recent years. According to the World Health Organization (WHO), breast cancer is a common disease occurring in women due to variations in the reproductive patterns, increased life expectancy, and the adoption of the western lifestyle. After skin cancer, breast cancer is the most commonly diagnosed disease.

The key regions taken into consideration for the study and analysis of the global market trends are Asia Pacific, North America, Europe, Latin America, and Rest of the World. The leading country with increasing awareness about cancer screening programs, the presence of deep-rooted healthcare facilities, and the convinient accessibility to early diagnostic procedures is the North America. Whereas Asia-Pacific with increasing number of breast and skin cancer cases along with improving healthcare infrastructure is expected to exhibit the highest growth rate over the forecast period 2020-2027

Major market players of non-opioid treatment included in this report are Danaher Corporation, Intuitive Surgical, Inc., Hologic Inc., Boston Scientific Corporation, Dune Medical Devices Ltd., Veran Medical Technologies, Cytogen Corporation, InnoMedicus AG, Becton, Dickinson and Company and others.

Marketed Biopsy Devices

Dune Medical Devices developed the first in-man Smart Biopsy device. It is a percutaneous soft tissue device which support the real-time tissue characterization with the help of radio-frequency (RF) spectroscopy technology. The company completed its trial for the device in June, 2019.

Sertera biopsy device by Hologic Inc., is ultrasound-guided breast biopsy device. It is a light weighted, easy to arm and fire device available in multiple gauge sizes. It is one of the best core needle biopsy devices.

SPiN Thoracic Navigation System® by Veran Medical Technologies is an electromagnetic navigation bronchoscopy and electromagnetic navigation for early lung cancer diagnoses. It involves a single procedure for both that is, from getting a diagnosis to preparing tissue sample for treatment.

Expect™ Pulmonary developed by Boston Scientific Corporation is engineered to be used along with endobronchial ultrasound bronchoscopes. It is used in the ultrasound directed fine needle aspiration of the submucosal and extramural lesions of the tracheobronchial and the gastrointestinal tract.

SONABLATE by InnoMedicus AG is a High-Intensity Focussed Ultrasound (HIFU) device for targeted therapy of prostate cancer. It is an image-guided and non-invasive surgical system. The ultrasound energy is transferred through the rectal wall and focused at specific location within the prostate, it is then identified, characterized and confirmed by using the combination of Magnetic resonance imaging (MRI) and real-time ultrasound.

Impact of Covid-19 on Smart Biopsy Device Market

Recently, the globe has been affected by the outbreak of COVID-19 pandemic. This has led to major drop in world’s economic status and many companies are even shut. However, the global Smart Biopsy Devices market has experienced an elevated demand and also the demand for other indispensable medical supplies is increased. This rise in demand is to avoid the transmission of the novel coronavirus infectious diseases, as well as offer ideal care to the patient, which further promote the market growth in the forthcoming years.